Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > "We are very pleased with the enrollment rate..."
View:
Post by BlaineBorg on Jul 07, 2021 9:17am

"We are very pleased with the enrollment rate..."

for IPF and CC? Seriously?! A 20 person study that was last due to report data in Q1 and Q2 2021 and the CEO is pleased? I mean that guy doesn't have a clue. BB
Comment by MoneyTalks22 on Jul 07, 2021 9:27am
so you are selling your shares then ??
Comment by BlaineBorg on Jul 07, 2021 10:15am
It's not relevant. What's relevant is the fact we all know the study is waaaay of track and the reason is because the CEO only has 6 locations across 2 countries. That's a needle in a haystack on steroids. He took a trial halfway around the world to save a couple of dollars in the grand scheme of things. Contrast that with Bells Health the CeO likes to spout about. They have north of ...more  
Comment by hk1966 on Jul 07, 2021 3:17pm
This stock is seriously hitting the skids because of lack of mgmt credibility. Speaking of hitting the skids- Perhaps they can do everyone a favour and acquaint themselves with the CDC guidance on swimming and diarrhea. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities